Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial

Title
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial
Authors
Keywords
-
Journal
LANCET
Volume 372, Issue 9652, Pages 1809-1818
Publisher
Elsevier BV
Online
2008-11-22
DOI
10.1016/s0140-6736(08)61758-4

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started